Biotransformation of xenobiotics in the human colon and rectum and its association with colorectal cancer

References

• Adler V, Yin Z, Fuchs SY, et al. (1999). Regulation of JNK signaling by GSTp. EMBO J 18:1321–1334
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan AN, Du M, Berndt SI, et al. (2014). Red meat intake, NAT2, and risk of colorectal cancer: A pooled analysis of 11 studies. Cancer Epidemiol Biomarkers Prev 24:198–205
   PubMed Web of Science ®Google Scholar
• Andersson T, Regardh CG, Lou YC, et al. (1992). Polymorphic hydroxylation of S-mephenytoin and omeprazole metabolism in Caucasian and Chinese subjects. Pharmacogenetics 2:25–31
   PubMedGoogle Scholar
• Androutsopoulos VP, Spyrou I, Ploumidis A, et al. (2013). Expression profile of CYP1A1 and CYP1B1 enzymes in colon and bladder tumors. PLoS One 8:e82487
   PubMed Web of Science ®Google Scholar
• Angstadt AY, Berg A, Zhu J, et al. (2013). The effect of copy number variation in the phase II detoxification genes UGT2B17 and UGT2B28 on colorectal cancer risk. Cancer 119:2477–2485
   PubMed Web of Science ®Google Scholar
• Angstadt AY, Hartman TJ, Lesko SM, et al. (2014). The effect of UGT1A and UGT2B polymorphisms on colorectal cancer risk: Haplotype associations and gene-environment interactions. Genes Chromosomes Cancer 53:454–466
   PubMed Web of Science ®Google Scholar
• Badal S, Delgoda R. (2013). CYP1B1: Friend or foe? A critical review. OA Biochemistry 1:8
   Google Scholar
• Badal S, Shields M, Delgoda R. (2012). Cytochrome P450 enzyme inhibitors from nature. In: Sharma PR, ed. Enzyme inhibition and bioapplications. Rijeka, Croatia: InTech, 39–56
   Google Scholar
• Baldwin RM, Shultz MA, Buckpitt AR. (2005). Bioactivation of the pulmonary toxicants naphthalene and 1-nitronaphthalene by rat CYP2F4. J Pharmacol Exp Ther 312:857–865
   PubMed Web of Science ®Google Scholar
• Bamber DE, Fryer AA, Strange RC, et al. (2001). Phenol sulphotransferase SULT1A1*1 genotype is associated with reduced risk of colorectal cancer. Pharmacogenetics 11:679–685
   PubMedGoogle Scholar
• Barrett JH, Smith G, Waxman R, et al. (2003). Investigation of interaction between N-acetyltransferase 2 and heterocyclic amines as potential risk factors for colorectal cancer. Carcinogenesis 24:275–282
   PubMed Web of Science ®Google Scholar
• Basu NK, Kubota S, Meselhy MR, et al. (2004). Gastrointestinally distributed UDP-glucuronosyltransferase 1A10, which metabolizes estrogens and nonsteroidal anti-inflammatory drugs, depends upon phosphorylation. J Biol Chem 279:28320–28329
   PubMed Web of Science ®Google Scholar
• Bedford MR, Anathhanam S, Saleh D, et al. (2012). Response of glutathione S-transferase Pi (GSTP1) to neoadjuvant therapy in rectal adenocarcinoma. Colorectal Dis 14:1483–1488
   PubMed Web of Science ®Google Scholar
• Bell DA, Taylor JA, Paulson DF, et al. (1993). Genetic risk and carcinogen exposure: A common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 85:1159–1164
   PubMed Web of Science ®Google Scholar
• Bergheim I, Bode C, Parlesak A. (2005a). Decreased expression of cytochrome P450 protein in non-malignant colonic tissue of patients with colonic adenoma. BMC Gastroenterol 5:34
   PubMed Web of Science ®Google Scholar
• Bergheim I, Bode C, Parlesak A. (2005b). Distribution of cytochrome P450 2C, 2E1, 3A4, and 3A5 in human colon mucosa. BMC Clin Pharmacol 5:4
   PubMedGoogle Scholar
• Bernard O, Guillemette C. (2004). The main role of UGT1A9 in the hepatic metabolism of mycophenolic acid and the effects of naturally occurring variants. Drug Metab Dispos 32:775–778
   PubMed Web of Science ®Google Scholar
• Beverage JN, Sissung TM, Sion AM, et al. (2007). CYP2D6 polymorphisms and the impact on tamoxifen therapy. J Pharm Sci 96:2224–2231
   PubMed Web of Science ®Google Scholar
• Bhasker CR, Mckinnon W, Stone A, et al. (2000). Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: Ethnic diversity of alleles and potential clinical significance. Pharmacogenetics 10:679–685
   PubMedGoogle Scholar
• Bigler J, Whitton J, Lampe JW, et al. (2001). CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk. Cancer Res 61:3566–3569
   PubMed Web of Science ®Google Scholar
• Bingham SA, Day NE, Luben R, et al. (2003). Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): An observational study. Lancet 361:1496–1501
   PubMed Web of Science ®Google Scholar
• Board PG. (1998). Identification of cDNAs encoding two human alpha class glutathione transferases (GSTA3 and GSTA4) and the heterologous expression of GSTA4-4. Biochem J 330:827–831
   PubMed Web of Science ®Google Scholar
• Bogaards JJ, Verhagen H, Willems MI, et al. (1994). Consumption of Brussels sprouts results in elevated alpha-class glutathione S-transferase levels in human blood plasma. Carcinogenesis 15:1073–1075
   PubMed Web of Science ®Google Scholar
• Boukouvala S, Fakis G. (2005). Arylamine N-acetyltransferases: What we learn from genes and genomes. Drug Metab Rev 37:511–564
   PubMed Web of Science ®Google Scholar
• Burchell B, Hume R. (1999). Molecular genetic basis of Gilbert’s syndrome. J Gastroenterol Hepatol 14:960–966
   PubMed Web of Science ®Google Scholar
• Buters J, Quintanilla-Martinez L, Schober W, et al. (2003). CYP1B1 determines susceptibility to low doses of 7,12-dimethylbenz[a]anthracene-induced ovarian cancers in mice: Correlation of CYP1B1-mediated DNA adducts with carcinogenicity. Carcinogenesis 24:327–334
   PubMed Web of Science ®Google Scholar
• Butler LM, Duguay Y, Millikan RC, et al. (2005). Joint effects between UDP-glucuronosyltransferase 1A7 genotype and dietary carcinogen exposure on risk of colon cancer. Cancer Epidemiol Biomarkers Prev 14:1626–1232
   PubMed Web of Science ®Google Scholar
• Carlini LE, Meropol NJ, Bever J, et al. (2005). UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan. Clin Cancer Res 11:1226–1236
   PubMed Web of Science ®Google Scholar
• Carr BA, Wan J, Hines RN, Yost GS. (2003). Characterization of the human lung CYP2F1 gene and identification of a novel lung-specific binding motif. J Biol Chem 278:15473–15483
   PubMed Web of Science ®Google Scholar
• Chan AT, Hsu M, Zauber AG, et al. (2012). The influence of UGT1A6 variants and aspirin use in a randomized trial of celecoxib for prevention of colorectal adenoma. Cancer Prev Res (Phila) 5:61–72
   PubMed Web of Science ®Google Scholar
• Chan AT, Tranah GJ, Giovannucci EL, et al. (2005a). Genetic variants in the UGT1A6 enzyme, aspirin use, and the risk of colorectal adenoma. J Natl Cancer Inst 97:457–460
   PubMed Web of Science ®Google Scholar
• Chan AT, Tranah GJ, Giovannucci EL, et al. (2005b). Prospective study of N-acetyltransferase-2 genotypes, meat intake, smoking and risk of colorectal cancer. Int J Cancer 115:648–652
   PubMed Web of Science ®Google Scholar
• Chang H, Su JM, Huang CC, et al. (2005). Using a combination of cytochrome P450 1B1 and beta-catenin for early diagnosis and prevention of colorectal cancer. Cancer Detect Prev 29:562–569
   PubMedGoogle Scholar
• Chen J, Stampfer MJ, Hough HL, et al. (1998). A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer. Cancer Res 58:3307–3311
   PubMed Web of Science ®Google Scholar
• Chen K, Jiang QT, He HQ. (2005). Relationship between metabolic enzyme polymorphism and colorectal cancer. World J Gastroenterol 11:331–335
   PubMed Web of Science ®Google Scholar
• Chen N, Whitehead SE, Caillat AW, et al. (2002). Identification and cross-species comparisons of CYP2F subfamily genes in mammals. Mutat Res 499:155–161
   PubMed Web of Science ®Google Scholar
• Chia WK, Ali R, Toh HC. (2012). Aspirin as adjuvant therapy for colorectal cancer – Reinterpreting paradigms. Nat Rev Clin Oncol 9:561–570
   PubMed Web of Science ®Google Scholar
• Chou HC, Lang NP, Kadlubar FF. (1995). Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s). Cancer Res 55:525–529
   PubMed Web of Science ®Google Scholar
• Ciotti M, Marrone A, Potter C, Owens IS. (1997). Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: Pharmacological implications. Pharmacogenetics 7:485–495
   PubMedGoogle Scholar
• Clapper ML, Hoffman SJ, Tew KD. (1991). Glutathione S-transferases in normal and malignant human colon tissue. Biochim Biophys Acta 1096:209–216
   PubMed Web of Science ®Google Scholar
• Clapper ML, Szarka CE, Pfeiffer GR, et al. (1997). Preclinical and clinical evaluation of broccoli supplements as inducers of glutathione S-transferase activity. Clin Cancer Res 3:25–30
   PubMed Web of Science ®Google Scholar
• Coffman BL, Rios GR, King CD, Tephly TR. (1997). Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab Dispos 25:1–4
   PubMed Web of Science ®Google Scholar
• Coles BF, Anderson KE, Doerge DR, et al. (2000). Quantitative analysis of interindividual variation of glutathione S-transferase expression in human pancreas and the ambiguity of correlating genotype with phenotype. Cancer Res 60:573–579
   PubMed Web of Science ®Google Scholar
• Coles BF, Chen G, Kadlubar FF, Radominska-Pandya A. (2002). Interindividual variation and organ-specific patterns of glutathione S-transferase alpha, mu, and pi expression in gastrointestinal tract mucosa of normal individuals. Arch Biochem Biophys 403:270–276
   PubMed Web of Science ®Google Scholar
• Coles BF, Kadlubar FF. (2005). Human alpha class glutathione S-transferases: Genetic polymorphism, expression, and susceptibility to disease. Methods Enzymol 401:9–42
   PubMed Web of Science ®Google Scholar
• Coles BF, Morel F, Rauch C, et al. (2001). Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression. Pharmacogenetics 11:663–669
   PubMedGoogle Scholar
• Court MH, Duan SX, Von Moltke LL, et al. (2001). Interindividual variability in acetaminophen glucuronidation by human liver microsomes: Identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms. J Pharmacol Exp Ther 299:998–1006
   PubMed Web of Science ®Google Scholar
• Court MH, Zhang X, Ding X, et al. (2012). Quantitative distribution of mRNAs encoding the 19 human UDP-glucuronosyltransferase enzymes in 26 adult and 3 fetal tissues. Xenobiotica 42:266–277
   PubMed Web of Science ®Google Scholar
• Cross JT, Poole EM, Ulrich CM. (2008). A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia. Pharmacogenomics J 8:237–247
   PubMed Web of Science ®Google Scholar
• Da Silva TD, Felipe AV, De Lima JM, et al. (2011). N-Acetyltransferase 2 genetic polymorphisms and risk of colorectal cancer. World J Gastroenterol 17:760–765
   PubMed Web of Science ®Google Scholar
• Dai D, Zeldin DC, Blaisdell JA, et al. (2001). Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid. Pharmacogenetics 11:597–607
   PubMedGoogle Scholar
• Daly AK. (1995). Molecular basis of polymorphic drug metabolism. J Mol Med (Berl) 73:539–553
   PubMed Web of Science ®Google Scholar
• Dang DT, Chen F, Kohli M, et al. (2005). Glutathione S-transferase pi1 promotes tumorigenicity in HCT116 human colon cancer cells. Cancer Res 65:9485–9494
   PubMed Web of Science ®Google Scholar
• De Jong MM, Nolte IM, Te Meerman GJ, et al. (2002). Low-penetrance genes and their involvement in colorectal cancer susceptibility. Cancer Epidemiol Biomarkers Prev 11:1332–1352
   PubMed Web of Science ®Google Scholar
• De Kok TM, Van Maanen JM. (2000). Evaluation of fecal mutagenicity and colorectal cancer risk. Mutat Res 463:53–101
   PubMed Web of Science ®Google Scholar
• De Waziers I, Cugnenc PH, Berger A, et al. (1991). Drug-metabolizing enzyme expression in human normal, peritumoral and tumoral colorectal tissue samples. Carcinogenesis 12:905–909
   PubMed Web of Science ®Google Scholar
• Dellinger RW, Chen G, Blevins-Primeau AS, et al. (2007). Glucuronidation of PhIP and N-OH-PhIP by UDP-glucuronosyltransferase 1A10. Carcinogenesis 28:2412–2418
   PubMed Web of Science ®Google Scholar
• Dellinger RW, Fang JL, Chen G, et al. (2006). Importance of UDP-glucuronosyltransferase 1A10 (UGT1A10) in the detoxification of polycyclic aromatic hydrocarbons: Decreased glucuronidative activity of the UGT1A10139Lys isoform. Drug Metab Dispos 34:943–949
   PubMed Web of Science ®Google Scholar
• Delozier TC, Kissling GE, Coulter SJ, et al. (2007). Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues. Drug Metab Dispos 35:682–688
   PubMed Web of Science ®Google Scholar
• Denson J, Xi Z, Wu Y, et al. (2006). Screening for inter-individual splicing differences in human GSTM4 and the discovery of a single nucleotide substitution related to the tandem skipping of two exons. Gene 379:148–155
   PubMed Web of Science ®Google Scholar
• Desmots F, Rissel M, Loyer P, et al. (2001). Immunohistological analysis of glutathione transferase A4 distribution in several human tissues using a specific polyclonal antibody. J Histochem Cytochem 49:1573–1580
   PubMed Web of Science ®Google Scholar
• Dey A. (2013). Cytochrome P450 2E1: Its clinical aspects and a brief perspective on the current research scenario. Subcell Biochem 67:1–104
   PubMedGoogle Scholar
• Din FV, Theodoratou E, Farrington SM, et al. (2010). Effect of aspirin and NSAIDs on risk and survival from colorectal cancer. Gut 59:1670–1679
   PubMed Web of Science ®Google Scholar
• Ding X, Kaminsky LS. (2003). Human extrahepatic cytochromes P450: Function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu Rev Pharmacol Toxicol 43:149–173
   PubMed Web of Science ®Google Scholar
• Dogru-Abbasoglu S, Mutlu-Turkoglu U, Turkoglu S, et al. (2002). Glutathione S-transferase-pi in malignant tissues and plasma of human colorectal and gastric cancers. J Cancer Res Clin Oncol 128:91–95
   PubMed Web of Science ®Google Scholar
• Doloff JC, Su T, Waxman DJ. (2010). Adenoviral delivery of pan-caspase inhibitor p35 enhances bystander killing by P450 gene-directed enzyme prodrug therapy using cyclophosphamide+. BMC Cancer 10:487
   PubMedGoogle Scholar
• Domanski TL, Finta C, Halpert JR, Zaphiropoulos PG. (2001). cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome P450. Mol Pharmacol 59:386–392
   PubMed Web of Science ®Google Scholar
• Dulik DM, Fenselau C, Hilton J. (1986). Characterization of melphalan-glutathione adducts whose formation is catalyzed by glutathione transferases. Biochem Pharmacol 35:3405–3409
   PubMed Web of Science ®Google Scholar
• Ebert MN, Klinder A, Peters WH, et al. (2003). Expression of glutathione S-transferases (GSTs) in human colon cells and inducibility of GSTM2 by butyrate. Carcinogenesis 24:1637–1644
   PubMed Web of Science ®Google Scholar
• Economopoulos KP, Sergentanis TN. (2010). GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: A comprehensive meta-analysis. Eur J Cancer 46:1617–1631
   PubMed Web of Science ®Google Scholar
• Edler D, Stenstedt K, Ohrling K, et al. (2009). The expression of the novel CYP2W1 enzyme is an independent prognostic factor in colorectal cancer – A pilot study. Eur J Cancer 45:705–712
   PubMed Web of Science ®Google Scholar
• Eimoto H, Tsutsumi M, Nakajima A, et al. (1988). Expression of the glutathione S-transferase placental form in human lung carcinomas. Carcinogenesis 9:2325–2327
   PubMed Web of Science ®Google Scholar
• Evans WE, Relling MV. (1999). Pharmacogenomics: Translating functional genomics into rational therapeutics. Science 286:487–491
   PubMed Web of Science ®Google Scholar
• Fernandez-Salguero P, Gonzalez FJ. (1995). The CYP2A gene subfamily: Species differences, regulation, catalytic activities and role in chemical carcinogenesis. Pharmacogenetics 5:S123–S128
   PubMedGoogle Scholar
• Fernandez-Salguero P, Hoffman SM, Cholerton S, et al. (1995). A genetic polymorphism in coumarin 7-hydroxylation: Sequence of the human CYP2A genes and identification of variant CYP2A6 alleles. Am J Hum Genet 57:651–660
   PubMed Web of Science ®Google Scholar
• Fisher MB, Paine MF, Strelevitz TJ, Wrighton SA. (2001). The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism. Drug Metab Rev 33:273–297
   PubMed Web of Science ®Google Scholar
• Flossmann E, Rothwell PM, British Doctors Aspirin Trial, The UK-TIA Aspirin Trial. (2007). Effect of aspirin on long-term risk of colorectal cancer: Consistent evidence from randomised and observational studies. Lancet 369:1603–1613
   PubMed Web of Science ®Google Scholar
• Fontana RJ, Lown KS, Paine MF, et al. (1999). Effects of a chargrilled meat diet on expression of CYP3A, CYP1A, and P-glycoprotein levels in healthy volunteers. Gastroenterology 117:89–98
   PubMed Web of Science ®Google Scholar
• Fuchs C, Mitchell EP, Hoff PM. (2006). Irinotecan in the treatment of colorectal cancer. Cancer Treat Rev 32:491–503
   PubMed Web of Science ®Google Scholar
• Gaitanarou E, Seretis E, Xinopoulos D, et al. (2008). Immunohistochemical localization of glutathione S-transferase-pi in human colorectal polyps. World J Gastroenterol 14:4179–4184
   PubMed Web of Science ®Google Scholar
• Gallagher CJ, Muscat JE, Hicks AN, et al. (2007). The UDP-glucuronosyltransferase 2B17 gene deletion polymorphism: Sex-specific association with urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol glucuronidation phenotype and risk for lung cancer. Cancer Epidemiol Biomarkers Prev 16:823–828
   PubMed Web of Science ®Google Scholar
• Gaudiano G, Koch TH, Lo Bello M, et al. (2000). Lack of glutathione conjugation to adriamycin in human breast cancer MCF-7/DOX cells. Inhibition of glutathione S-transferase p1-1 by glutathione conjugates from anthracyclines. Biochem Pharmacol 60:1915–1923
   PubMed Web of Science ®Google Scholar
• Gervot L, Carriere V, Costet P, et al. (1996). CYP3A5 is the major cytochrome P450 3A expressed in human colon and colonic cell lines. Environ Toxicol Pharmacol 2:381–388
   PubMed Web of Science ®Google Scholar
• Gervot L, Rochat B, Gautier JC, et al. (1999). Human CYP2B6: Expression, inducibility and catalytic activities. Pharmacogenetics 9:295–306
   PubMedGoogle Scholar
• Gibson G, Skett P. (2001). Introduction to drug metabolism. Cheltenham UK: Nelson Thornes Ltd
   Google Scholar
• Gibson P, Gill JH, Khan PA, et al. (2003). Cytochrome P450 1B1 (CYP1B1) is overexpressed in human colon adenocarcinomas relative to normal colon: Implications for drug development. Mol Cancer Ther 2:527–534
   PubMed Web of Science ®Google Scholar
• Girard H, Butler LM, Villeneuve L, et al. (2008). UGT1A1 and UGT1A9 functional variants, meat intake, and colon cancer, among Caucasians and African-Americans. Mutat Res 644:56–63
   PubMed Web of Science ®Google Scholar
• Girard H, Court MH, Bernard O, et al. (2004). Identification of common polymorphisms in the promoter of the UGT1A9 gene: Evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver. Pharmacogenetics 14:501–515
   PubMedGoogle Scholar
• Giuliani L, Ciotti M, Stoppacciaro A, et al. (2005). UDP-glucuronosyltransferases 1A expression in human urinary bladder and colon cancer by immunohistochemistry. Oncol Rep 13:185–191
   PubMed Web of Science ®Google Scholar
• Goetz MP, Rae JM, Suman VJ, et al. (2005). Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes. J Clin Oncol 23:9312–9318
   PubMed Web of Science ®Google Scholar
• Goldstein JA. (2001). Clinical relevance of genetic polymorphisms in the human CYP2C subfamily. Br J Clin Pharmacol 52:349–355
   PubMed Web of Science ®Google Scholar
• Goldstein JA, De Morais SM. (1994). Biochemistry and molecular biology of the human CYP2C subfamily. Pharmacogenetics 4:285–299
   PubMedGoogle Scholar
• Gomez A, Karlgren M, Edler D, et al. (2007). Expression of CYP2W1 in colon tumors: Regulation by gene methylation. Pharmacogenomics 8:1315–1325
   PubMed Web of Science ®Google Scholar
• Gong QH, Cho JW, Huang T, et al. (2001). Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics 11:357–368
   PubMedGoogle Scholar
• Gonzalez FJ, Gelboin HV. (1994). Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metab Rev 26:165–183
   PubMed Web of Science ®Google Scholar
• Green MD, Oturu EM, Tephly TR. (1994). Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates. Drug Metab Dispos 22:799–805
   PubMed Web of Science ®Google Scholar
• Gregory PA, Lewinsky RH, Gardner-Stephen DA, Mackenzie PI. (2004). Regulation of UDP glucuronosyltransferases in the gastrointestinal tract. Toxicol Appl Pharmacol 199:354–363
   PubMed Web of Science ®Google Scholar
• Grubben MJ, Nagengast FM, Katan MB, Peters WHM. (2001). The glutathione biotransformation system and colorectal cancer risk in humans. Scand J Gastroenterol 36:68–76
   Web of Science ®Google Scholar
• Grubben MJ, Van Den Braak CC, Broekhuizen R, et al. (2000a). The effect of unfiltered coffee on potential biomarkers for colonic cancer risk in healthy volunteers: A randomized trial. Aliment Pharmacol Ther 14:1181–1190
   PubMed Web of Science ®Google Scholar
• Grubben MJ, Van Den Braak CC, Nagengast FM, Peters WH. (2006). Low colonic glutathione detoxification capacity in patients at risk for colon cancer. Eur J Clin Invest 36:188–192
   PubMed Web of Science ®Google Scholar
• Grubben MJ, Van Den Braak CC, Peters WH, et al. (2000b). Low levels of colonic glutathione S-transferase in patients with X-linked agammaglobulinaemia. Eur J Clin Invest 30:642–645
   PubMed Web of Science ®Google Scholar
• Guengerich FP. (2003). Cytochromes P450, drugs, and diseases. Mol Interv 3:194–204
   PubMedGoogle Scholar
• Guengerich FP, Tang Z, Salamanca-Pinzon SG, Cheng Q. (2010). Characterizing proteins of unknown function: Orphan cytochrome p450 enzymes as a paradigm. Mol Interv 10:153–163
   PubMed Web of Science ®Google Scholar
• Guillemette C, Levesque E, Harvey M, et al. (2010). UGT genomic diversity: Beyond gene duplication. Drug Metab Rev 42:24–44
   PubMed Web of Science ®Google Scholar
• Hamada K, Umemoto A, Kajikawa A, et al. (1994). Mucosa-specific DNA adducts in human small intestine: A comparison with the colon. Carcinogenesis 15:2677–2680
   PubMed Web of Science ®Google Scholar
• Hanioka N, Naito T, Narimatsu S. (2008). Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation. Chemosphere 74:33–36
   PubMed Web of Science ®Google Scholar
• Harding D, Fournel-Gigleux S, Jackson MR, Burchell B. (1988). Cloning and substrate specificity of a human phenol UDP-glucuronosyltransferase expressed in COS-7 cells. Proc Natl Acad Sci USA 85:8381–8385
   PubMed Web of Science ®Google Scholar
• Harris RM, Picton R, Singh S, Waring RH. (2000). Activity of phenolsulfotransferases in the human gastrointestinal tract. Life Sci 67:2051–2057
   PubMed Web of Science ®Google Scholar
• Harrison DJ, Kharbanda R, Bishop D, et al. (1989). Glutathione S-transferase isoenzymes in human renal carcinoma demonstrated by immunohistochemistry. Carcinogenesis 10:1257–1260
   PubMed Web of Science ®Google Scholar
• Hayes JD, Flanagan JU, Jowsey IR. (2005). Glutathione transferases. Annu Rev Pharmacol Toxicol 45:51–88
   PubMed Web of Science ®Google Scholar
• Hayes JD, Pulford DJ. (1995). The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30:445–600
   PubMed Web of Science ®Google Scholar
• Hengstler JG, Bottger T, Tanner B, et al. (1998). Resistance factors in colon cancer tissue and the adjacent normal colon tissue: Glutathione S-transferases alpha and pi, glutathione and aldehyde dehydrogenase. Cancer Lett 128:105–112
   PubMed Web of Science ®Google Scholar
• Hoensch H, Morgenstern I, Petereit G, et al. (2002). Influence of clinical factors, diet, and drugs on the human upper gastrointestinal glutathione system. Gut 50:235–240
   PubMed Web of Science ®Google Scholar
• Hoensch H, Peters WH, Roelofs HM, Kirch W. (2006). Expression of the glutathione enzyme system of human colon mucosa by localisation, gender and age. Curr Med Res Opin 22:1075–1083
   PubMed Web of Science ®Google Scholar
• Hoensch HP, Roelofs HM, Edler L, et al. (2013). Disparities of conjugating protective enzyme activities in the colon of patients with adenomas and carcinomas. World J Gastroenterol 19:6020–6025
   PubMed Web of Science ®Google Scholar
• Hofmann MH, Blievernicht JK, Klein K, et al. (2008). Aberrant splicing caused by single nucleotide polymorphism c.516G > T [Q172H], a marker of CYP2B6*6, is responsible for decreased expression and activity of CYP2B6 in liver. J Pharmacol Exp Ther 325:284–292
   PubMed Web of Science ®Google Scholar
• Holthe M, Klepstad P, Zahlsen K, et al. (2002). Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy. Eur J Clin Pharmacol 58:353–356
   PubMed Web of Science ®Google Scholar
• Horton JK, Roy G, Piper JT, et al. (1999). Characterization of a chlorambucil-resistant human ovarian carcinoma cell line overexpressing glutathione S-transferase mu. Biochem Pharmacol 58:693–702
   PubMed Web of Science ®Google Scholar
• Houlston RS, Tomlinson IP. (2001). Polymorphisms and colorectal tumor risk. Gastroenterology 121:282–301
   PubMed Web of Science ®Google Scholar
• Howie AF, Forrester LM, Glancey MJ, et al. (1990). Glutathione S-transferase and glutathione peroxidase expression in normal and tumour human tissues. Carcinogenesis 11:451–458
   PubMed Web of Science ®Google Scholar
• Huang YH, Galijatovic A, Nguyen N, et al. (2002). Identification and functional characterization of UDP-glucuronosyltransferases UGT1A8*1, UGT1A8*2 and UGT1A8*3. Pharmacogenetics 12:287–297
   PubMedGoogle Scholar
• Hubatsch I, Ridderstrom M, Mannervik B. (1998). Human glutathione transferase A4-4: An alpha class enzyme with high catalytic efficiency in the conjugation of 4-hydroxynonenal and other genotoxic products of lipid peroxidation. Biochem J 330:175–179
   PubMed Web of Science ®Google Scholar
• Husain A, Zhang X, Doll MA, et al. (2007). Identification of N-acetyltransferase 2 (NAT2) transcription start sites and quantitation of NAT2-specific mRNA in human tissues. Drug Metab Dispos 35:721–777
   PubMed Web of Science ®Google Scholar
• Ingelman-Sundberg M. (2005). Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): Clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J 5:6–13
   PubMed Web of Science ®Google Scholar
• Ingelman-Sundberg M, Sim SC, Gomez A, Rodriguez-Antona C. (2007). Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol Ther 116:496–526
   PubMed Web of Science ®Google Scholar
• Ishikawa T, Ali-Osman F. (1993). Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance. J Biol Chem 268:20116–20125
   PubMed Web of Science ®Google Scholar
• Jaitovitch-Groisman I, Fotouhi-Ardakani N, Schecter RL, et al. (2000). Modulation of glutathione S-transferase alpha by hepatitis B virus and the chemopreventive drug oltipraz. J Biol Chem 275:33395–33403
   PubMed Web of Science ®Google Scholar
• Jakobsson J, Ekstrom L, Inotsume N, et al. (2006). Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism. J Clin Endocrinol Metab 91:687–693
   PubMed Web of Science ®Google Scholar
• Jiang JG, Chen CL, Card JW, et al. (2005). Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors. Cancer Res 65:4707–4715
   PubMed Web of Science ®Google Scholar
• Jin C, Miners JO, Lillywhite KJ, Mackenzie PI. (1993a). Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs. J Pharmacol Exp Ther 264:475–479
   PubMed Web of Science ®Google Scholar
• Jin CJ, Miners JO, Burchell B, Mackenzie PI. (1993b). The glucuronidation of hydroxylated metabolites of benzo[a]pyrene and 2-acetylaminofluorene by cDNA-expressed human UDP-glucuronosyltransferases. Carcinogenesis 14:2637–2639
   PubMed Web of Science ®Google Scholar
• Jinno H, Tanaka-Kagawa T, Ohno A, et al. (2003). Functional characterization of cytochrome P450 2B6 allelic variants. Drug Metab Dispos 31:398–403
   PubMed Web of Science ®Google Scholar
• Johansson AS, Mannervik B. (2001). Human glutathione transferase A3-3, a highly efficient catalyst of double-bond isomerization in the biosynthetic pathway of steroid hormones. J Biol Chem 276:33061–33065
   PubMed Web of Science ®Google Scholar
• Johnson CM, Wei C, Ensor JE, et al. (2013). Meta-analyses of colorectal cancer risk factors. Cancer Causes Control 24:1207–1222
   PubMed Web of Science ®Google Scholar
• Jordan VC. (1982). Metabolites of tamoxifen in animals and man: Identification, pharmacology, and significance. Breast Cancer Res Treat 2:123–138
   PubMedGoogle Scholar
• Jordan VC. (1993). Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer. Br J Pharmacol 110:507–517
   PubMed Web of Science ®Google Scholar
• Jordan VC, Collins MM, Rowsby L, Prestwich G. (1977). A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity. J Endocrinol 75:305–316
   PubMed Web of Science ®Google Scholar
• Kantor RR, Giardina SL, Bartolazzi A, et al. (1991). Monoclonal antibodies to glutathione S-transferase pi-immunohistochemical analysis of human tissues and cancers. Int J Cancer 47:193–201
   PubMed Web of Science ®Google Scholar
• Karlgren M, Gomez A, Stark K, et al. (2006). Tumor-specific expression of the novel cytochrome P450 enzyme, CYP2W1. Biochem Biophys Res Commun 341:451–458
   PubMed Web of Science ®Google Scholar
• Katoh T, Yamano Y, Tsuji M, Watanabe M. (2008). Genetic polymorphisms of human cytosol glutathione S-transferases and prostate cancer. Pharmacogenomics 9:93–104
   PubMed Web of Science ®Google Scholar
• Kawato Y, Aonuma M, Hirota Y, et al. (1991). Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11. Cancer Res 51:4187–4191
   PubMed Web of Science ®Google Scholar
• Kim J, Coss CC, Barrett CM, et al. (2013). Role and pharmacologic significance of cytochrome P-450 2D6 in oxidative metabolism of toremifene and tamoxifen. Int J Cancer 132:1475–1485
   PubMed Web of Science ®Google Scholar
• Kim SH, Kwon HC, Oh SY, et al. (2009). Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer. Am J Clin Oncol 32:38–43
   PubMed Web of Science ®Google Scholar
• King CD, Rios GR, Green MD, Tephly TR. (2000). UDP-glucuronosyltransferases. Curr Drug Metab 1:143–161
   PubMed Web of Science ®Google Scholar
• Kiss I, Sandor J, Pajkos G, et al. (2000). Colorectal cancer risk in relation to genetic polymorphism of cytochrome P450 1A1, 2E1, and glutathione-S-transferase M1 enzymes. Anticancer Res 20:519–522
   PubMed Web of Science ®Google Scholar
• Kitada M, Kamataki T, Itahashi K, et al. (1985). Purification and properties of cytochrome P-450 from homogenates of human fetal livers. Arch Biochem Biophys 241:275–280
   PubMed Web of Science ®Google Scholar
• Kivisto KT, Kroemer HK, Eichelbaum M. (1995). The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: Implications for drug interactions. Br J Clin Pharmacol 40:523–530
   PubMed Web of Science ®Google Scholar
• Kiyohara C. (2000). Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of colorectal cancer. J Epidemiol 10:349–360
   PubMedGoogle Scholar
• Klein K, Zanger UM. (2013). Pharmacogenomics of cytochrome P450 3A4: Recent progress toward the “missing heritability” problem. Front Genet 4:12
   PubMedGoogle Scholar
• Klose TS, Blaisdell JA, Goldstein JA. (1999). Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs. J Biochem Mol Toxicol 13:289–295
   PubMed Web of Science ®Google Scholar
• Klotz U, Hoensch H, Schuetz T, et al. (1998). Expression of intestinal drug-metabolising enzymes in patients with chronic inflammatory bowel disease. Curr Therapeut Res 59:556–563
   Web of Science ®Google Scholar
• Kroemer HK, Eichelbaum M. (1995). “It’s the genes, stupid”. Molecular bases and clinical consequences of genetic cytochrome P450 2D6 polymorphism. Life Sci 56:2285–2298
   PubMed Web of Science ®Google Scholar
• Kuehl GE, Bigler J, Potter JD, Lampe JW. (2006). Glucuronidation of the aspirin metabolite salicylic acid by expressed UDP-glucuronosyltransferases and human liver microsomes. Drug Metab Dispos 34:199–202
   PubMed Web of Science ®Google Scholar
• Kumarakulasingham M, Rooney PH, Dundas SR, et al. (2005). Cytochrome p450 profile of colorectal cancer: Identification of markers of prognosis. Clin Cancer Res 11:3758–3765
   PubMed Web of Science ®Google Scholar
• Laborde E. (2010). Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death. Cell Death Differ 17:1373–1380
   PubMed Web of Science ®Google Scholar
• Lafuente A, Pujol F, Carretero P, et al. (1993). Human glutathione S-transferase mu (GST mu) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Lett 68:49–54
   PubMed Web of Science ®Google Scholar
• Lampe JW, Chen C, Li S, et al. (2000). Modulation of human glutathione S-transferases by botanically defined vegetable diets. Cancer Epidemiol Biomarkers Prev 9:787–793
   PubMed Web of Science ®Google Scholar
• Lanza DL, Code E, Crespi CL, et al. (1999). Specific dehydrogenation of 3-methylindole and epoxidation of naphthalene by recombinant human CYP2F1 expressed in lymphoblastoid cells. Drug Metab Dispos 27:798–803
   PubMed Web of Science ®Google Scholar
• Lanza DL, Yost GS. (2001). Selective dehydrogenation/oxygenation of 3-methylindole by cytochrome p450 enzymes. Drug Metab Dispos 29:950–953
   PubMed Web of Science ®Google Scholar
• Lee CR, Goldstein JA, Pieper JA. (2002). Cytochrome P450 2C9 polymorphisms: A comprehensive review of the in-vitro and human data. Pharmacogenetics 12:251–263
   PubMedGoogle Scholar
• Leskela S, Honrado E, Montero-Conde C, et al. (2007). Cytochrome P450 3A5 is highly expressed in normal prostate cells but absent in prostate cancer. Endocr Relat Cancer 14:645–654
   PubMed Web of Science ®Google Scholar
• Lilla C, Verla-Tebit E, Risch A, et al. (2006). Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption. Cancer Epidemiol Biomarkers Prev 15:99–107
   PubMed Web of Science ®Google Scholar
• Linder MW, Prough RA, Valdes R Jr. (1997). Pharmacogenetics: A laboratory tool for optimizing therapeutic efficiency. Clin Chem 43:254–266
   PubMed Web of Science ®Google Scholar
• Mackenzie PI, Bock KW, Burchell B, et al. (2005). Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 15:677–685
   PubMed Web of Science ®Google Scholar
• Mannervik B, Board PG, Hayes JD, et al. (2005). Nomenclature for mammalian soluble glutathione transferases. Methods Enzymol 401:1–8
   PubMed Web of Science ®Google Scholar
• Matsuda Y, Saoo K, Yamakawa K, et al. (2007). Overexpression of CYP2A6 in human colorectal tumors. Cancer Sci 98:1582–1585
   PubMed Web of Science ®Google Scholar
• Mccarroll SA, Hadnott TN, Perry GH, et al. (2006). Common deletion polymorphisms in the human genome. Nat Genet 38:86–92
   PubMed Web of Science ®Google Scholar
• McIlwain CC, Townsend DM, Tew KD. (2006). Glutathione S-transferase polymorphisms: Cancer incidence and therapy. Oncogene 25:1639–1648
   PubMed Web of Science ®Google Scholar
• Mega JL, Close SL, Wiviott SD, et al. (2009). Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med 360:354–362
   PubMed Web of Science ®Google Scholar
• Mercurio MG, Shiff SJ, Galbraith RA, Sassa S. (1995). Expression of cytochrome P450 mRNAs in the colon and the rectum in normal human subjects. Biochem Biophys Res Commun 210:350–355
   PubMed Web of Science ®Google Scholar
• Meyer UA. (1996). Overview of enzymes of drug metabolism. J Pharmacokinet Biopharm 24:449–459
   PubMedGoogle Scholar
• Miles JS, Mclaren AW, Forrester LM, et al. (1990). Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity. Biochem J 267:365–371
   PubMed Web of Science ®Google Scholar
• Miners JO, Mackenzie PI, Knights KM. (2010). The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro–in vivo extrapolation of drug clearance and drug-drug interaction potential. Drug Metab Rev 42:196–208
   PubMed Web of Science ®Google Scholar
• Moorghen M, Cairns J, Forrester LM, et al. (1991). Enhanced expression of glutathione S-transferases in colorectal carcinoma compared to non-neoplastic mucosa. Carcinogenesis 12:13–17
   PubMed Web of Science ®Google Scholar
• Morel F, Fardel O, Meyer DJ, et al. (1993). Preferential increase of glutathione S-transferase class alpha transcripts in cultured human hepatocytes by phenobarbital, 3-methylcholanthrene, and dithiolethiones. Cancer Res 53:231–234
   PubMed Web of Science ®Google Scholar
• Morel F, Rauch C, Coles B, et al. (2002). The human glutathione transferase alpha locus: Genomic organization of the gene cluster and functional characterization of the genetic polymorphism in the hGSTA1 promoter. Pharmacogenetics 12:277–286
   PubMedGoogle Scholar
• Moreno V, Glatt H, Guino E, et al. (2005). Polymorphisms in sulfotransferases SULT1A1 and SULT1A2 are not related to colorectal cancer. Int J Cancer 113:683–686
   PubMed Web of Science ®Google Scholar
• Moscow JA, Fairchild CR, Madden MJ, et al. (1989). Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res 49:1422–1428
   PubMed Web of Science ®Google Scholar
• Mulder TP, Court DA, Peters WH. (1999). Variability of glutathione S-transferase alpha in human liver and plasma. Clin Chem 45:355–359
   PubMed Web of Science ®Google Scholar
• Mulder TP, Verspaget HW, Sier CF, et al. (1995). Glutathione S-transferase pi in colorectal tumors is predictive for overall survival. Cancer Res 55:2696–2702
   PubMed Web of Science ®Google Scholar
• Murray GI, Melvin WT, Greenlee WF, Burke MD. (2001). Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1. Annu Rev Pharmacol Toxicol 41:297–316
   PubMed Web of Science ®Google Scholar
• Murray GI, Taylor MC, Mcfadyen MC, et al. (1997). Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res 57:3026–3031
   PubMed Web of Science ®Google Scholar
• Nagar S, Zalatoris JJ, Blanchard RL. (2004). Human UGT1A6 pharmacogenetics: Identification of a novel SNP, characterization of allele frequencies and functional analysis of recombinant allozymes in human liver tissue and in cultured cells. Pharmacogenetics 14:487–499
   PubMedGoogle Scholar
• Naidu KA, Nasir A, Pinkas H, et al. (2003). Glutathione-S-transferase pi expression and activity is increased in colonic neoplasia. In Vivo 17:479–482
   PubMed Web of Science ®Google Scholar
• Nakajima M, Yamamoto T, Nunoya K, et al. (1996a). Characterization of CYP2A6 involved in 3′-hydroxylation of cotinine in human liver microsomes. J Pharmacol Exp Ther 277:1010–1015
   PubMed Web of Science ®Google Scholar
• Nakajima M, Yamamoto T, Nunoya K, et al. (1996b). Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metab Dispos 24:1212–1217
   PubMed Web of Science ®Google Scholar
• Nakamura A, Nakajima M, Yamanaka H, et al. (2008). Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines. Drug Metab Dispos 36:1461–1464
   PubMed Web of Science ®Google Scholar
• Nakamura K, Yoshihara S, Shimada T, Guengerich FP. (1999). Selection and characterization of human cytochrome P450 1B1 mutants by random mutagenesis. ISSX Proceedings of the 9th North American ISSX Meeting, Nashville, TN, vol. 15, p. 62
   Google Scholar
• Nebert DW, Jones JE. (1989). Regulation of the mammalian cytochrome P1-450 (CYP1A1) gene. Int J Biochem 21:243–252
   PubMedGoogle Scholar
• Nelson DR, Koymans L, Kamataki T, et al. (1996). P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6:1–42
   PubMedGoogle Scholar
• Nhamburo PT, Kimura S, Mcbride OW, et al. (1990). The human CYP2F gene subfamily: Identification of a cDNA encoding a new cytochrome P450, cDNA-directed expression, and chromosome mapping. Biochemistry 29:5491–5499
   PubMed Web of Science ®Google Scholar
• Nichols WK, Mehta R, Skordos K, et al. (2003). 3-Methylindole-induced toxicity to human bronchial epithelial cell lines. Toxicol Sci 71:229–236
   PubMed Web of Science ®Google Scholar
• Nijhoff WA, Grubben MJ, Nagengast FM, et al. (1995a). Effects of consumption of Brussels sprouts on intestinal and lymphocytic glutathione S-transferases in humans. Carcinogenesis 16:2125–2128
   PubMed Web of Science ®Google Scholar
• Nijhoff WA, Mulder TP, Verhagen H, et al. (1995b). Effects of consumption of brussels sprouts on plasma and urinary glutathione S-transferase class-alpha and -pi in humans. Carcinogenesis 16:955–957
   PubMed Web of Science ®Google Scholar
• Nishida CR, Lee M, De Montellano PR. (2010). Efficient hypoxic activation of the anticancer agent AQ4N by CYP2S1 and CYP2W1. Mol Pharmacol 78:497–502
   PubMed Web of Science ®Google Scholar
• Nothlings U, Yamamoto JF, Wilkens LR, et al. (2009). Meat and heterocyclic amine intake, smoking, NAT1 and NAT2 polymorphisms, and colorectal cancer risk in the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 18:2098–2106
   PubMed Web of Science ®Google Scholar
• Nowell S, Coles B, Sinha R, et al. (2002). Analysis of total meat intake and exposure to individual heterocyclic amines in a case-control study of colorectal cancer: Contribution of metabolic variation to risk. Mutat Res 506–507:175–185
   PubMed Web of Science ®Google Scholar
• O’Dwyer PJ, Szarka CE, Yao KS, et al. (1996). Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz. J Clin Invest 98:1210–1217
   PubMed Web of Science ®Google Scholar
• Oakley A. (2011). Glutathione transferases: A structural perspective. Drug Metab Rev 43:138–151
   PubMed Web of Science ®Google Scholar
• Ognjanovic S, Yamamoto J, Maskarinec G, Le Marchand L. (2006). NAT2, meat consumption and colorectal cancer incidence: An ecological study among 27 countries. Cancer Causes Control 17:1175–1182
   PubMed Web of Science ®Google Scholar
• Olson KC, Dellinger RW, Zhong Q, et al. (2009). Functional characterization of low-prevalence missense polymorphisms in the UDP-glucuronosyltransferase 1A9 gene. Drug Metab Dispos 37:1999–2007
   PubMed Web of Science ®Google Scholar
• Orzechowski A, Schrenk D, Bock-Hennig BS, Bock KW. (1994). Glucuronidation of carcinogenic arylamines and their N-hydroxy derivatives by rat and human phenol UDP-glucuronosyltransferase of the UGT1 gene complex. Carcinogenesis 15:1549–1553
   PubMed Web of Science ®Google Scholar
• Oyama T, Kagawa N, Kunugita N, et al. (2004). Expression of cytochrome P450 in tumor tissues and its association with cancer development. Front Biosci 9:1967–1976
   PubMed Web of Science ®Google Scholar
• Patana AS, Kurkela M, Finel M, Goldman A. (2008). Mutation analysis in UGT1A9 suggests a relationship between substrate and catalytic residues in UDP-glucuronosyltransferases. Protein Eng Des Sel 21:537–543
   PubMed Web of Science ®Google Scholar
• Patterson LH, Murray GI. (2002). Tumour cytochrome P450 and drug activation. Curr Pharm Des 8:1335–1347
   PubMed Web of Science ®Google Scholar
• Pavek P, Dvorak Z. (2008). Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues. Curr Drug Metab 9:129–143
   PubMed Web of Science ®Google Scholar
• Pearson WR, Vorachek WR, Xu SJ, et al. (1993). Identification of class-mu glutathione transferase genes GSTM1-GSTM5 on human chromosome 1p13. Am J Hum Genet 53:220–233
   PubMed Web of Science ®Google Scholar
• Pelkonen O, Raunio H. (1995). Individual expression of carcinogen-metabolizing enzymes: Cytochrome P4502A. J Occup Environ Med 37:19–24
   PubMed Web of Science ®Google Scholar
• Peng CT, Chen JC, Yeh KT, et al. (2003). The relationship among the polymorphisms of SULT1A1, 1A2 and different types of cancers in Taiwanese. Int J Mol Med 11:85–89
   PubMed Web of Science ®Google Scholar
• Peters WH, Kock L, Nagengast FM, Kremers PG. (1991). Biotransformation enzymes in human intestine: Critical low levels in the colon? Gut 32:408–412
   PubMed Web of Science ®Google Scholar
• Peters WH, Nagengast FM, Wobbes T. (1989). Glutathione S-transferases in normal and cancerous human colon tissue. Carcinogenesis 10:2371–2374
   PubMed Web of Science ®Google Scholar
• Peters WH, Roelofs HM. (1992). Biochemical characterization of resistance to mitoxantrone and adriamycin in Caco-2 human colon adenocarcinoma cells: A possible role for glutathione S-transferases. Cancer Res 52:1886–1890
   PubMed Web of Science ®Google Scholar
• Peters WH, Roelofs HM, Hectors MP, et al. (1993). Glutathione and glutathione S-transferases in Barrett’s epithelium. Br J Cancer 67:1413–1417
   PubMed Web of Science ®Google Scholar
• Pfohl-Leszkowicz A, Grosse Y, Carriere V, et al. (1995). High levels of DNA adducts in human colon are associated with colorectal cancer. Cancer Res 55:5611–5616
   PubMed Web of Science ®Google Scholar
• Plewka D, Plewka A, Szczepanik T, et al. (2014). Expression of selected cytochrome P450 isoforms and of cooperating enzymes in colorectal tissues in selected pathological conditions. Pathol Res Pract 210:242–249
   PubMed Web of Science ®Google Scholar
• Potter GA, Patterson LH, Wanogho E, et al. (2002). The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. Br J Cancer 86:774–778
   PubMed Web of Science ®Google Scholar
• Quattrochi LC, Tukey RH. (1989). The human cytochrome Cyp1A2 gene contains regulatory elements responsive to 3-methylcholanthrene. Mol Pharmacol 36:66–71
   PubMed Web of Science ®Google Scholar
• Ranganathan S, Tew KD. (1991). Immunohistochemical localization of glutathione S-transferases alpha, mu, and pi in normal tissue and carcinomas from human colon. Carcinogenesis 12:2383–2387
   PubMed Web of Science ®Google Scholar
• Rendic S, Guengerich FP. (2012). Contributions of human enzymes in carcinogen metabolism. Chem Res Toxicol 25:1316–1383
   PubMed Web of Science ®Google Scholar
• Rieger MA, Ebner R, Bell DR, et al. (2004). Identification of a novel mammary-restricted cytochrome P450, CYP4Z1, with overexpression in breast carcinoma. Cancer Res 64:2357–2364
   PubMed Web of Science ®Google Scholar
• Ross VL, Board PG, Webb GC. (1993). Chromosomal mapping of the human Mu class glutathione S-transferases to 1p13. Genomics 18:87–91
   PubMed Web of Science ®Google Scholar
• Rostami-Hodjegan A, Tucker GT. (2007). Simulation and prediction of in vivo drug metabolism in human populations from in vitro data. Nat Rev Drug Discov 6:140–148
   PubMed Web of Science ®Google Scholar
• Rothwell PM, Price JF, Fowkes FG, et al. (2012). Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: Analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet 379:1602–1612
   PubMed Web of Science ®Google Scholar
• Rothwell PM, Wilson M, Elwin CE, et al. (2010). Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-Year follow-up of five randomised trials. Lancet 376:1741–1750
   PubMed Web of Science ®Google Scholar
• Sachse C, Smith G, Wilkie MJ, et al. (2002). A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis 23:1839–1849
   PubMed Web of Science ®Google Scholar
• Salonpaa P, Hakkola J, Pasanen M, et al. (1993). Retrovirus-mediated stable expression of human CYP2A6 in mammalian cells. Eur J Pharmacol 248:95–102
   PubMed Web of Science ®Google Scholar
• Samowitz WS, Wolff RK, Curtin K, et al. (2006). Interactions between CYP2C9 and UGT1A6 polymorphisms and nonsteroidal anti-inflammatory drugs in colorectal cancer prevention. Clin Gastroenterol Hepatol 4:894–901
   PubMed Web of Science ®Google Scholar
• Schuetz JD, Beach DL, Guzelian PS. (1994). Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. Pharmacogenetics 4:11–20
   PubMedGoogle Scholar
• Sheehan D, Meade G, Foley VM, Dowd CA. (2001). Structure, function and evolution of glutathione transferases: Implications for classification of non-mammalian members of an ancient enzyme superfamily. Biochem J 360:1–16
   PubMed Web of Science ®Google Scholar
• Shimada T, Yamazaki H, Mimura M, et al. (1996). Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs. Drug Metab Dispos 24:515–522
   PubMed Web of Science ®Google Scholar
• Shou M, Korzekwa KR, Krausz KW, et al. (1996). Specificity of cDNA-expressed human and rodent cytochrome P450s in the oxidative metabolism of the potent carcinogen 7,12-dimethylbenz[a]anthracene. Mol Carcinog 17:241–249
   PubMed Web of Science ®Google Scholar
• Smith TJ, Stoner GD, Yang CS. (1995). Activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung microsomes by cytochromes P450, lipoxygenase, and hydroperoxides. Cancer Res 55:5566–5573
   PubMed Web of Science ®Google Scholar
• Sorensen M, Autrup H, Olsen A, et al. (2008). Prospective study of NAT1 and NAT2 polymorphisms, tobacco smoking and meat consumption and risk of colorectal cancer. Cancer Lett 266:186–193
   PubMed Web of Science ®Google Scholar
• Stenstedt K, Hallstrom M, Johansson I, et al. (2012). The expression of CYP2W1: A prognostic marker in colon cancer. Anticancer Res 32:3869–3874
   PubMed Web of Science ®Google Scholar
• Stiborova M, Borek-Dohalska L, Hodek P, et al. (2002a). New selective inhibitors of cytochromes P450 2B and their application to antimutagenesis of tamoxifen. Arch Biochem Biophys 403:41–49
   PubMed Web of Science ®Google Scholar
• Stiborova M, Martinek V, Rydlova H, et al. (2002b). Sudan I is a potential carcinogen for humans: Evidence for its metabolic activation and detoxication by human recombinant cytochrome P450 1A1 and liver microsomes. Cancer Res 62:5678–5684
   PubMed Web of Science ®Google Scholar
• Stiborova M, Martinek V, Rydlova H, et al. (2005). Expression of cytochrome P450 1A1 and its contribution to oxidation of a potential human carcinogen 1-phenylazo-2-naphthol (Sudan I) in human livers. Cancer Lett 220:145–154
   PubMed Web of Science ®Google Scholar
• Strange RC, Fryer AA. (1999). The glutathione S-transferases: Influence of polymorphism on cancer susceptibility. IARC Sci Publ 148:231–249
   PubMedGoogle Scholar
• Strange RC, Matharoo B, Faulder GC, et al. (1991). The human glutathione S-transferases: A case-control study of the incidence of the GST1 0 phenotype in patients with adenocarcinoma. Carcinogenesis 12:25–28
   PubMed Web of Science ®Google Scholar
• Strassburg CP, Manns MP, Tukey RH. (1997a). Differential down-regulation of the UDP-glucuronosyltransferase 1A locus is an early event in human liver and biliary cancer. Cancer Res 57:2979–2985
   PubMed Web of Science ®Google Scholar
• Strassburg CP, Nguyen N, Manns MP, Tukey RH. (1998). Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium. Mol Pharmacol 54:647–654
   PubMed Web of Science ®Google Scholar
• Strassburg CP, Nguyen N, Manns MP, Tukey RH. (1999). UDP-glucuronosyltransferase activity in human liver and colon. Gastroenterology 116:149–160
   PubMed Web of Science ®Google Scholar
• Strassburg CP, Oldhafer K, Manns MP, Tukey RH. (1997b). Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: Identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue. Mol Pharmacol 52:212–220
   PubMed Web of Science ®Google Scholar
• Strassburg CP, Vogel A, Kneip S, et al. (2002). Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer. Gut 50:851–856
   PubMed Web of Science ®Google Scholar
• Stresser DM, Kupfer D. (1999). Monospecific antipeptide antibody to cytochrome P-450 2B6. Drug Metab Dispos 27:517–525
   PubMed Web of Science ®Google Scholar
• Su T, Sheng JJ, Lipinskas TW, Ding X. (1996). Expression of CYP2A genes in rodent and human nasal mucosa. Drug Metab Dispos 24:884–890
   PubMed Web of Science ®Google Scholar
• Sutoh I, Kohno H, Nakashima Y, et al. (2000). Concurrent expressions of metallothionein, glutathione S-transferase-pi, and P-glycoprotein in colorectal cancers. Dis Colon Rectum 43:221–232
   PubMed Web of Science ®Google Scholar
• Swanson C, Mellstrom D, Lorentzon M, et al. (2007). The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men. J Clin Endocrinol Metab 92:4878–4882
   PubMed Web of Science ®Google Scholar
• Taioli E, Flores-Obando RE, Agalliu I, et al. (2011). Multi-institutional prostate cancer study of genetic susceptibility in populations of African descent. Carcinogenesis 32:1361–1365
   PubMed Web of Science ®Google Scholar
• Tan KL, Jankova L, Chan C, et al. (2011). Clinicopathological correlates and prognostic significance of glutathione S-transferase Pi expression in 468 patients after potentially curative resection of node-positive colonic cancer. Histopathology 59:1057–1070
   PubMed Web of Science ®Google Scholar
• Tan Z, Feng M, Luo Y, et al. (2013). GSTP1 Ile105Val polymorphism and colorectal cancer risk: An updated analysis. Gene 527:275–282
   PubMed Web of Science ®Google Scholar
• Tang J, Cao Y, Rose RL, et al. (2001). Metabolism of chlorpyrifos by human cytochrome P450 isoforms and human, mouse, and rat liver microsomes. Drug Metab Dispos 29:1201–1204
   PubMed Web of Science ®Google Scholar
• Tang J, Cao Y, Rose RL, Hodgson E. (2002). In vitro metabolism of carbaryl by human cytochrome P450 and its inhibition by chlorpyrifos. Chem Biol Interact 141:229–241
   PubMed Web of Science ®Google Scholar
• Teh LK, Bertilsson L. (2012). Pharmacogenomics of CYP2D6: Molecular genetics, interethnic differences and clinical importance. Drug Metab Pharmacokinet 27:55–67
   PubMed Web of Science ®Google Scholar
• Thorn M, Finnstrom N, Lundgren S, et al. (2005). Cytochromes P450 and MDR1 mRNA expression along the human gastrointestinal tract. Br J Clin Pharmacol 60:54–60
   PubMed Web of Science ®Google Scholar
• Tiemersma EW, Bunschoten A, Kok FJ, et al. (2004a). Effect of SULT1A1 and NAT2 genetic polymorphism on the association between cigarette smoking and colorectal adenomas. Int J Cancer 108:97–103
   PubMed Web of Science ®Google Scholar
• Tiemersma EW, Kampman E, Bueno De Mesquita HB, et al. (2002). Meat consumption, cigarette smoking, and genetic susceptibility in the etiology of colorectal cancer: Results from a Dutch prospective study. Cancer Causes Control 13:383–393
   PubMed Web of Science ®Google Scholar
• Tiemersma EW, Voskuil DW, Bunschoten A, et al. (2004b). Risk of colorectal adenomas in relation to meat consumption, meat preparation, and genetic susceptibility in a Dutch population. Cancer Causes Control 15:225–236
   PubMed Web of Science ®Google Scholar
• Townsend DM, Tew KD. (2003). The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 22:7369–7375
   PubMed Web of Science ®Google Scholar
• Tukey RH, Strassburg CP. (2000). Human UDP-glucuronosyltransferases: Metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 40:581–616
   PubMed Web of Science ®Google Scholar
• Tukey RH, Strassburg CP, Mackenzie PI. (2002). Pharmacogenomics of human UDP-glucuronosyltransferases and irinotecan toxicity. Mol Pharmacol 62:446–450
   PubMed Web of Science ®Google Scholar
• Umemoto A, Kajikawa A, Tanaka M, et al. (1994). Presence of mucosa-specific DNA adduct in human colon: Possible implication for colorectal cancer. Carcinogenesis 15:901–905
   PubMed Web of Science ®Google Scholar
• Usmani KA, Rose RL, Goldstein JA, et al. (2002). In vitro human metabolism and interactions of repellent N,N-diethyl-m-toluamide. Drug Metab Dispos 30:289–294
   PubMed Web of Science ®Google Scholar
• Vaclavikova R, Hubackova M, Stribrna-Sarmanova J, et al. (2007). RNA expression of cytochrome P450 in breast cancer patients. Anticancer Res 27:4443–4450
   PubMed Web of Science ®Google Scholar
• Van Der Logt EM, Bergevoet SM, Roelofs HM, et al. (2004). Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk. Carcinogenesis 25:2407–2415
   PubMed Web of Science ®Google Scholar
• Van Lieshout EM, Peters WH, Jansen JB. (1996). Effect of oltipraz, alpha-tocopherol, beta-carotene and phenethylisothiocyanate on rat oesophageal, gastric, colonic and hepatic glutathione, glutathione S-transferase and peroxidase. Carcinogenesis 17:1439–1445
   PubMed Web of Science ®Google Scholar
• Van Poppel G, De Vogel N, Van Balderen PJ, Kok FJ. (1992). Increased cytogenetic damage in smokers deficient in glutathione S-transferase isozyme mu. Carcinogenesis 13:303–305
   PubMed Web of Science ®Google Scholar
• Verhulst ML, Van Oijen AH, Roelofs HM, et al. (2000). Antral glutathione concentration and glutathione S-transferase activity in patients with and without Helicobacter pylori. Dig Dis Sci 45:629–632
   PubMed Web of Science ®Google Scholar
• Vlaykova TGM, Yovchev Y, Dimov D, et al. (2012). Glutathione-S-transferases in development, progression and therapy of colorectal cancer. Chapter 5. In: Ettarh DR, ed. Colorectal cancer biology – From genes to tumor. Rijeka, Croatia: InTech, 81–106
   Google Scholar
• Wahab PJ, Peters WH, Roelofs HM, Jansen JB. (2001). Glutathione S-transferases in small intestinal mucosa of patients with coeliac disease. Jpn J Cancer Res 92:279–284
   PubMedGoogle Scholar
• Wang D, Dubois RN. (2012). Epoxyeicosatrienoic acids: A double-edged sword in cardiovascular diseases and cancer. J Clin Invest 122:19–22
   PubMed Web of Science ®Google Scholar
• Wang H, Lanza DL, Yost GS. (1998). Cloning and expression of CYP2F3, a cytochrome P450 that bioactivates the selective pneumotoxins 3-methylindole and naphthalene. Arch Biochem Biophys 349:329–340
   PubMed Web of Science ®Google Scholar
• Wang H, Yamamoto JF, Caberto C, et al. (2011). Genetic variation in the bioactivation pathway for polycyclic hydrocarbons and heterocyclic amines in relation to risk of colorectal neoplasia. Carcinogenesis 32:203–209
   PubMed Web of Science ®Google Scholar
• Wang M, Qi YY, Chen S, et al. (2012). Expression of UDP-glucuronosyltransferase 1A, nuclear factor erythroid-E2-related factor 2 and Kelch-like ECH-associated protein 1 in colonic mucosa, adenoma and adenocarcinoma tissue. Oncol Lett 4:925–930
   PubMed Web of Science ®Google Scholar
• Wang M, Sun DF, Wang S, et al. (2013). Polymorphic expression of UDP-glucuronosyltransferase UGTlA gene in human colorectal cancer. PLoS One 8:e57045
   Google Scholar
• Wark PA, Grubben MJ, Peters WH, et al. (2004). Habitual consumption of fruits and vegetables: Associations with human rectal glutathione S-transferase. Carcinogenesis 25:2135–2142
   PubMed Web of Science ®Google Scholar
• Welfare MR, Cooper J, Bassendine MF, Daly AK. (1997). Relationship between acetylator status, smoking, and diet and colorectal cancer risk in the north-east of England. Carcinogenesis 18:1351–1354
   PubMed Web of Science ®Google Scholar
• Westlind A, Malmebo S, Johansson I, et al. (2001). Cloning and tissue distribution of a novel human cytochrome p450 of the CYP3A subfamily, CYP3A43. Biochem Biophys Res Commun 281:1349–1355
   PubMed Web of Science ®Google Scholar
• Wiencke JK, Pemble S, Ketterer B, Kelsey KT. (1995). Gene deletion of glutathione S-transferase theta: Correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol Biomarkers Prev 4:253–259
   PubMed Web of Science ®Google Scholar
• Williams JA, Ring BJ, Cantrell VE, et al. (2002). Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7. Drug Metab Dispos 30:883–891
   PubMed Web of Science ®Google Scholar
• Wong CF, Liyou N, Leggett B, et al. (2002). Association of the SULT1A1 R213H polymorphism with colorectal cancer. Clin Exp Pharmacol Physiol 29:754–758
   PubMed Web of Science ®Google Scholar
• Wu ZL, Sohl CD, Shimada T, Guengerich FP. (2006). Recombinant enzymes overexpressed in bacteria show broad catalytic specificity of human cytochrome P450 2W1 and limited activity of human cytochrome P450 2S1. Mol Pharmacol 69:2007–2014
   PubMed Web of Science ®Google Scholar
• Xiao J, Zheng Y, Zhou Y, et al. (2014). Sulfotransferase SULT1A1 Arg213His polymorphism with cancer risk: A meta-analysis of 53 case-control studies. PLoS One 9:e106774
   PubMed Web of Science ®Google Scholar
• Xie HG, Wood AJ, Kim RB, et al. (2004). Genetic variability in CYP3A5 and its possible consequences. Pharmacogenomics 5:243–272
   PubMed Web of Science ®Google Scholar
• Xu S, Wang Y, Roe B, Pearson WR. (1998). Characterization of the human class Mu glutathione S-transferase gene cluster and the GSTM1 deletion. J Biol Chem 273:3517–3527
   PubMed Web of Science ®Google Scholar
• Yamano S, Tatsuno J, Gonzalez FJ. (1990). The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. Biochemistry 29:1322–1329
   PubMed Web of Science ®Google Scholar
• Ye Z, Parry JM. (2003). A meta-analysis of 20 case-control studies of the glutathione S-transferase M1 (GSTM1) status and colorectal cancer risk. Med Sci Monit 9:SR83–SR91
   PubMedGoogle Scholar
• Yengi LG, Xiang Q, Pan J, et al. (2003). Quantitation of cytochrome P450 mRNA levels in human skin. Anal Biochem 316:103–110
   PubMed Web of Science ®Google Scholar
• Yun CH, Shimada T, Guengerich FP. (1991). Purification and characterization of human liver microsomal cytochrome P-450 2A6. Mol Pharmacol 40:679–685
   PubMed Web of Science ®Google Scholar
• Zanger UM, Schwab M. (2013). Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther 138:103–141
   PubMed Web of Science ®Google Scholar
• Zanger UM, Turpeinen M, Klein K, Schwab M. (2008). Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation. Anal Bioanal Chem 392:1093–1108
   PubMed Web of Science ®Google Scholar
• Zeldin DC, Dubois RN, Falck JR, Capdevila JH. (1995). Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform. Arch Biochem Biophys 322:76–86
   PubMed Web of Science ®Google Scholar
• Zeldin DC, Moomaw CR, Jesse N, et al. (1996). Biochemical characterization of the human liver cytochrome P450 arachidonic acid epoxygenase pathway. Arch Biochem Biophys 330:87–96
   PubMed Web of Science ®Google Scholar
• Zhang ZJ, Hao K, Shi R, et al. (2011). Glutathione S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) null polymorphisms, smoking, and their interaction in oral cancer: A HuGE review and meta-analysis. Am J Epidemiol 173:847–857
   PubMed Web of Science ®Google Scholar
• Zhou SF, Chan E, Zhou ZW, et al. (2009). Insights into the structure, function, and regulation of human cytochrome P450 1A2. Curr Drug Metab 10:713–729
   PubMed Web of Science ®Google Scholar
• Zhou SF, Wang B, Yang LP, Liu JP. (2010). Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2. Drug Metab Rev 42:268–354
   PubMed Web of Science ®Google Scholar